Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis | MicrobiomeTrials← Back to trialsNCT06880770
Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2025-04-24Est. Completion: 2029-03
Enrollment target: 288 participants Locations- Research Site, Los Angeles, California, United States
- Clinical Research Site 4, Santa Clarita, California, United States
- Research Site, New Haven, Connecticut, United States
- Clinical Research Site 6, Springfield, Illinois, United States
- Research Site, Indianapolis, Indiana, United States
- Research Site, Kansas City, Kansas, United States
- Research Site, Ann Arbor, Michigan, United States
- Research Site, St Louis, Missouri, United States
- Clinical Research Site 5, North Platte, Nebraska, United States
- Clinical Research Site 3, Greensboro, North Carolina, United States
- Research Site, Wilmington, North Carolina, United States
- Clinical Research Site 7, Philadelphia, Pennsylvania, United States
- Research Site, Pittsburgh, Pennsylvania, United States
- Clinical Research Site 1, Mesquite, Texas, United States
- Clinical Research Site 2, San Antonio, Texas, United States
- Research Site, Seattle, Washington, United States
- Research Site, Ramos Mejía, Buenos Aires, Argentina
Other microbiome trials you might be interested in
CardiovascularMetabolic DiseaseDyslipidemiasLipid DisorderHypertriglyceridemiaHeterozygous Familial Hypercholesterolemia (HeFH)Homozygous Familial Hypercholesterolemia (HoFH)Severe Hypertriglyceridemia (sHTG)Mixed HyperlipemiaHypercholesterolaemia
This is a single-arm, open-label, multicenter, ascending dose Phase 1 trial that will enroll participants 18 to 75 years…
Hialeah, United StatesEst. completion Jun 2027
Research Site, Córdoba, Córdoba Province, ArgentinaResearch Site, Córdoba, Córdoba Province, ArgentinaResearch Site, Rosario, Santa Fe Province, ArgentinaResearch Site, Ciudad Autonoma Buenos Aires, ArgentinaResearch Site, Graz, AustriaResearch Site, Linz, AustriaResearch Site, Vienna, AustriaResearch Site, Fortaleza, Ceará, BrazilResearch Site, Belo Horizonte, Minas Gerais, BrazilResearch Site, Belo Horizonte, Minas Gerais, BrazilResearch Site, Belo Horizonte, Minas Gerais, BrazilResearch Site, Curitiba, Paraná, BrazilResearch Site, Porto Alegre, Rio Grande do Sul, BrazilResearch Site, Porto Alegre, Rio Grande do Sul, BrazilResearch Site, Pôrto Alegre, Rio Grande do Sul, BrazilResearch Site, São Paulo, São Paulo, BrazilResearch Site, São Paulo, São Paulo, BrazilResearch Site, São Paulo, BrazilResearch Site, Burgas, BulgariaResearch Site, Pleven, BulgariaResearch Center, Plovdiv, BulgariaResearch Site, Plovdiv, BulgariaResearch Site, Rousse, BulgariaResearch Site, Sofia, BulgariaResearch Site, Sofia, BulgariaResearch Site, Stara Zagora, BulgariaResearch Center, Beijing, Beijing Municipality, ChinaResearch Site, Guiyang, Guizhou, ChinaResearch Site, Harbin, Heilongjiang, ChinaResearch Site, Luoyang, Henan, ChinaResearch Site, Luoyang, Henan, ChinaResearch Site, Zhuzhou, Hunan, ChinaResearch Center, Baotou, Inner Mongolia, ChinaResearch Site, Chifeng, Inner Mongolia, ChinaResearch Center, Nanchang, Jiangxi, ChinaResearch Center, Shanghai, Shanghai Municipality, ChinaResearch Site, Chengdu, Sichuan, ChinaResearch Center, Hangzhou, Zhejiang, ChinaResearch Site, Hangzhou, Zhejiang, ChinaResearch Site, Wenzhou, Zhejiang, ChinaResearch Site, Beijing, ChinaResearch Site, Changsha, ChinaResearch Site, Chengdu, ChinaResearch Site, Ch’ang-ch’un, ChinaResearch Site, Nanjing, ChinaResearch Site, Barranquilla, ColombiaResearch Site, Bogotá, ColombiaResearch Site, Bogotá, ColombiaResearch Site, Cali, ColombiaResearch Site, Cali, ColombiaResearch Site, Puerto Colombia, ColombiaResearch Site, Budapest, HungaryResearch Site, Budapest, HungaryResearch Site, Pécs, HungaryResearch Site, Szeged, HungaryResearch Site, Amman, JordanResearch Center, Amman, JordanResearch Site, Amman, JordanResearch Center, Irbid, JordanResearch Center, Irbid, JordanResearch Site, Guadalajara, Jalisco, MexicoResearch Site, Mexico City, Mexico City, MexicoResearch Site, Muscat, OmanResearch Site, Riyadh, Saudi ArabiaResearch Site, Riyadh, Saudi ArabiaResearch Site, Riyadh, Saudi ArabiaResearch Center, Belgrade, SerbiaResearch Site, Belgrade, SerbiaResearch Site, Pančevo, SerbiaResearch Center, Zaječar, SerbiaResearch Site, Singapore, SingaporeResearch Site, Seongnam-si, Gyeonggi-do, South KoreaResearch Site, Jeonju, Jeollabuk-do, South KoreaResearch Site, Busan, South KoreaResearch Site, Sejong, South KoreaResearch Site, Seoul, South KoreaResearch Site, Seoul, South KoreaResearch Site, Seoul, South KoreaResearch Site, Seoul, South KoreaResearch Center, Gothenburg, SwedenResearch Center, Stockholm, SwedenResearch Site, Abu Dhabi, United Arab EmiratesResearch Site, Abu Dhabi, United Arab EmiratesResearch Site, Al Ain City, United Arab EmiratesResearch Site, London, Greater London, United KingdomPhase 4
Recruiting
Hypertriglyceridemic Acute PancreatitisAcute Pancreatitis, Hypertriglyceridemia-inducedHyperlipidemia
Background: Hypertriglyceridemia-associated acute pancreatitis (HTG-AP) has become the second most common cause of acute…
Xiamen, ChinaEst. completion Jan 18, 2028